Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies.


Parkinson's disease is the most common neurodegenerative movement disorder, affecting about 6 million people worldwide with a slow progression of the symptoms. Its prevalence is expected to double in the most populated areas within the next two decades, according to increasing aged population. Consequently, Parkinson's disease is a socio-economic trouble… (More)
DOI: 10.1016/j.jbiotec.2011.08.004

1 Figure or Table


  • Presentations referencing similar topics